Matthew Skaruppa sold $3.5M of DUOL
Chief Financial Officer at Duolingo, Inc.. 10,937 shares at an average of $317.39, traded Aug 26, 2025, filed Aug 28, 2025.
Score components
- +22RoleCFO
- +25Trade size$3.5M at market
- +5Share of holdings soldSold 20% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.1%, 3m -41.6%, 6m -63.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001562088-25-000198, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 26, 2025 | MOption exercise Class A Common Stock10b5-1 | +1,378 | $14.42 | $20k | 54,282 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -500 | $311.38 | $156k | 53,782 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -300 | $312.67 | $94k | 53,482 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -755 | $314.16 | $237k | 52,727 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -1,402 | $315.27 | $442k | 51,325 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -2,301 | $316.24 | $728k | 49,024 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -800 | $317.44 | $254k | 48,224 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -1,501 | $318.36 | $478k | 46,723 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -700 | $319.33 | $224k | 46,023 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -1,100 | $320.50 | $353k | 44,923 | Aug 28, 2025 |
| Aug 26, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -1,578 | $321.33 | $507k | 43,345 | Aug 28, 2025 |
| Aug 26, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,378 | $0.00 | $0 | 0 | Aug 28, 2025 |
Related signals
Other insiders at Duolingo, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 16, 2026 | Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | $17M 110,046 shares | -100% | |
| 43Moderate | Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | $7.0M 46,682 shares | -100% | |
| 50Moderate | Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | $6.2M 40,980 shares | -110% | |
| 50Moderate | Duolingo, Inc. | Luis von Ahn President & CEO, Co-Founder | $4.3M 28,292 shares | -100% | |
| 40Moderate | Duolingo, Inc. | Stephen C. Chen General Counsel | $1.2M 8,072 shares | -16% | |
| 40Moderate | Duolingo, Inc. | William B Gordon director | $1.5M 10,000 shares | -13% | |
| 41Moderate | Duolingo, Inc. | Stephen C. Chen General Counsel | $132k 1,024 shares | -2% | |
| 41Moderate | Duolingo, Inc. | Robert Meese Chief Business Officer | $175k 1,354 shares | -1% | |
| 29Weak | Duolingo, Inc. | Natalie Glance Chief Engineering Officer | $567k 4,290 shares | -2% | |
| 24Weak | Duolingo, Inc. | Stephen C. Chen General Counsel | $317k 2,797 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.